Year archive

Bright Minds Biosciences Inc. — 2025 filings

All 20 regulatory filings released by Bright Minds Biosciences Inc. (DRUG) in 2025, sourced directly from the official regulator.

20 Filings

2025 Period

2025 filings (20)

Filing	Released	Lang
Annual information form - English.pdf Annual Report FY 2025	2025-12-24	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings FY 2025	2025-12-24	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-12-24	English
Annual MD&A - English.pdf Management Reports	2025-12-24	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-12-24	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-12-24	English
Audited annual financial statements – English.pdf Annual Report FY 2025	2025-12-24	English
News release - English.pdf Regulatory Filings	2025-11-17	English
News release - English.pdf Regulatory Filings	2025-11-07	English
News release - English.pdf Regulatory Filings	2025-11-07	English
News release - English.pdf Investor Presentation	2025-05-28	English
News release - English.pdf Regulatory Filings	2025-05-20	English
News release - English.pdf Capital/Financing Update	2025-03-04	French
News release - English.pdf Board/Management Information	2025-03-04	English
Other.pdf Proxy Solicitation & Information Statement	2025-02-21	English
Notice of meeting - English.pdf Regulatory Filings	2025-02-19	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-02-19	English
Other.pdf Report Publication Announcement	2025-02-19	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-01-21	English
News release - English.pdf Board/Management Information	2025-01-07	English